Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


THOMPSON JOHN CRAIG Create: Alert

All | News | Filings
Date FiledTypeDescription
01/09/2018 4 THOMPSON JOHN CRAIG (President & CEO) has filed a Form 4 on Anthera Pharmaceuticals Inc
Txns: Granted 1,847,074 options to buy @ $1.65, valued at $3M
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/07/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/07/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
02/06/2017 5 Form 5 - Annual statement of changes in beneficial ownership of securities
12/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/13/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/10/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $44.08, valued at $440.8k
Exercised 10,000 options to buy @ $14.45, valued at $144.5k
08/07/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $46.31, valued at $463.1k
Exercised 10,000 options to buy @ $14.45, valued at $144.5k
07/08/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $47.91, valued at $479.1k
Exercised 10,000 options to buy @ $14.45, valued at $144.5k
06/16/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $41.51, valued at $415.1k
Exercised 10,000 options to buy @ $14.45, valued at $144.5k
06/10/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 11,862 shares @ $43.5, valued at $516k
Sold 10,637 shares @ $43, valued at $457.4k
Exercised 22,499 options to buy @ $14.45, valued at $325.1k
05/19/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Sold 30,000 shares @ $39.63, valued at $1.2M
Exercised 30,000 options to buy @ $14.45, valued at $433.5k
01/09/2015 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Granted 100,000 options to buy @ $39.94, valued at $4M
02/05/2014 4 THOMPSON JOHN CRAIG (COO) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC
Txns: Granted 250,000 options to buy @ $14.45, valued at $3.6M
09/13/2013 4 THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Disposed/sold 2,455 shares @ $0
Disposed/sold 150,000 options to buy @ $4.3, valued at $645k
Disposed/sold 90,000 options to buy @ $4.8, valued at $432k
Disposed/sold 125,000 options to buy @ $6.13, valued at $766.3k
03/11/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/12/2012 4 THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Granted 90,000 options to buy @ $4.8, valued at $432k
01/11/2011 4 THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc
Txns: Granted 150,000 options to buy @ $4.3, valued at $645k
01/11/2011 3 THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 3 on Trius Therapeutics Inc

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy